Avoiding the Financial Toxicity of Cancer.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 42
- By:
- Publication type:
- Article
Works matching IS 2475823X AND DT 2021 AND VI 7 AND IP 2
Results: 23
1
2
A Guide to Kidney Cancer for Survivors and Caregivers: Empowerment Through Knowledge, Communication, and Self-Care.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 54
- By:
- Publication type:
- Article
3
Are COVID-19 Vaccines Safe and Effective for People with Cancer?
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 46
- By:
- Publication type:
- Article
4
The Big "C".
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 45
- By:
- Publication type:
- Article
5
Walk on Through Your Cancer Journey.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 39
- By:
- Publication type:
- Article
6
Dear Doctor.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 36
- By:
- Publication type:
- Article
7
How Mindfulness Meditation Can Help Cancer Survivors Cope with Stress.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 32
- By:
- Publication type:
- Article
8
Exposure to Occupational Toxins Increases the Risk for Lung Cancer.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 30
- By:
- Publication type:
- Article
9
Libtayo Approved for First-Line Treatment of Advanced Lung Cancer.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 29
- Publication type:
- Article
10
Libtayo Approved for Some Patients with Basal-Cell Carcinoma.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 29
- Publication type:
- Article
11
Deadly Kicks from the "C" Word.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 28
- By:
- Publication type:
- Article
12
FDA Approved Pepaxto for Relapsed or Refractory Multiple Myeloma.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 26
- Publication type:
- Article
13
FDA Approves Abecma, First CAR T-Cell Therapy for Multiple Myeloma.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 26
- Publication type:
- Article
14
Yescarta First Gene Therapy Approved for Follicular Lymphoma.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 25
- Publication type:
- Article
15
FDA Approved Ukoniq, New Targeted Therapy, for Marginal-Zone and Follicular Lymphoma.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 25
- Publication type:
- Article
16
FDA Approved Breyanzi, Novel Gene Therapy, for Large B-Cell Lymphoma.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 25
- Publication type:
- Article
17
Fertility Preservation in Young Adults with Cancer.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 22
- By:
- Publication type:
- Article
18
Despite No Sex, We Were Never So Married.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 19
- By:
- Publication type:
- Article
19
Climate Change Plays Havoc on Weather Patterns, and on Skin Cancer Rates.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 17
- By:
- Publication type:
- Article
20
Cancer Took My Breasts and Gave Me Self-Acceptance.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 15
- By:
- Publication type:
- Article
21
Life as Scary Monsters, or Big C & Lil' c.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 12
- By:
- Publication type:
- Article
22
No Pair, I Don't Care!
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 10
- By:
- Publication type:
- Article
23
Spring Forward and Onward.
- Published in:
- Conquer, 2021, v. 7, n. 2, p. 9
- By:
- Publication type:
- Article